Aakhir, numbers kya bol rahe hain?
Company ne Q3 FY2026 ke liye apne unaudited consolidated results announce kiye hain, aur numbers sach mein solid hain. Pichhle saal ke comparison mein, revenue 23.0% badhkar ₹530 Crore tak pahunch gaya. Aur agar Total Income ki baat karein toh yeh 21.8% badhkar ₹540 Crore ho gaya. Profitability bhi kamaal ki rahi - EBITDA 21.3% badhkar ₹155 Crore par pahuncha, jismein EBITDA margins 28.6% maintain kiye gaye. Sabse acchi baat Profit After Tax (PAT) mein dikhi, jo 54.5% jump kar ₹44 Crore ho gaya, aur PAT margins bhi 8.1% tak sudhar gaye.
Saath Mahino Ka Performance Bhi Mast Hai
Sirf Q3 hi nahi, pehle 9 mahine FY2026 ke liye bhi performance tagda raha hai. Total Income ₹1,548 Crore (+20.8% YoY) aur Revenue from Operations ₹1,516 Crore (+21.2% YoY) raha. EBITDA ₹440 Crore (+23.6% YoY) par pahuncha, jismein margins 28.4% rahe. PAT mein toh 74.3% ka zabardast uphaan dekhne ko mila, jo ₹118 Crore tak pahunch gaya.
Network Badh Raha Hai, Surgeries Bhi
Operational side par bhi company peeche nahi hai. Network ab 272 facilities tak pahunch gaya hai, jismein Q3 mein hi 14 naye centers add kiye gaye hain. Surgeries ki संख्या bhi 11.2% badhkar 81,002 ho gayi hai Q3 mein, jo demand ka ek accha signal hai.
Aage Ka Plan: Ethiopia Mein Entry!
Company management apne annual guidance ko lekar kaafi confident hai. Growth ke peeche resilient demand aur expansion plans hain. Unki strategy mein naye greenfield facilities banana, existing aur naye areas mein presence mazboot karna shamil hai. Lekin sabse bada move hai international foray – company Ethiopia mein ek wholly-owned subsidiary banane ja rahi hai, jiske liye unki Mauritius subsidiary Orbit Healthcare Services (Mauritius) Limited through yeh kaam hoga.
Iske alawa, Idearx Services Private Limited ab associate company nahi rahegi, haalanki Dr. Agarwal's Health Care Limited usmein 14.54% equity stake rakhegi. Registered office bhi Chennai mein shift hone wala hai.